Amesite Inc. filed a Current Report on Form 8-K with the SEC on September 11, 2026, to furnish presentation materials regarding its progress. The company intends to use these materials during the H.C. Wainwright 28th Annual Global Investment Conference, scheduled for September 14, 2026, through September 16, 2026.
The presentation, titled "Shareholder Update Q2 2027," outlines the company's focus on the post-acute care market. Amesite targets the $1.5 trillion U.S. post-acute market, which includes segments such as home care ($191.6B in 2026), home healthcare ($162.35B in 2024), hospice ($31.2B in 2025), skilled nursing ($199.72B in 2024), and senior living ($943.9B in 2025).
The company highlighted its product offerings, NurseMagic and LynkMagic. NurseMagic is described as a B2C app for documentation and a B2B platform for team administration. The presentation notes that the B2C app is designed for a single clinician per shift, while the B2B platform is intended for tens of caregivers per buyer. LynkMagic is presented as an enterprise solution for state program administration, custom workflows, and workforce learning.
Amesite detailed a pricing model for its services. For individual clinicians, the service is priced at $7.99 per month, with a free trial of seven days. For facilities and agencies, the pricing is a flat $1,099 per month for a census under 1,000, or $1 per census per month for a census of 1,000 or more. For LynkMagic solutions, pricing is structured per participant for fiscal intermediaries and senior-living REITs.
The filing also included details on the company's leadership and team. Dr. Ann Marie Sastry serves as the Founder, CEO, and Chair of the Board. The Board of Directors includes George Parmer, J. Michael Losh, Barbie Brewer, and Dr. Gilbert S. Omenn.
